Related Experiment Video
Updated: Jul 10, 2026
07:51
Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
Magnesium transport in hypertension
1Kidney Research Centre, University of Ottawa, Ottawa Health Research Institute, 451 Smyth Rd, #2513, K1H 8M5 Ottawa, ON, Canada.
Summary
Magnesium (Mg2+) deficiency is linked to high blood pressure. Specific cellular transport systems regulate magnesium, and their dysfunction may contribute to hypertension and cardiovascular disease.
Area of Science:
- Cardiovascular Physiology
- Molecular Biology
- Biochemistry
Background:
- Epidemiological, clinical, and experimental data suggest an inverse relationship between magnesium (Mg2+) levels and blood pressure.
- Magnesium influences blood pressure by affecting vascular tone and structure via biochemical pathways controlling vascular contraction/dilation, growth, differentiation, and inflammation.
- Magnesium acts as a calcium channel antagonist, promotes vasodilator production (prostacyclins, nitric oxide), and modulates vascular responses to vasoactive agents.
Purpose of the Study:
- To review the role of magnesium (Mg2+) in vascular biology and its implications in hypertension.
- To focus on the transport systems that regulate vascular magnesium homeostasis.
- To discuss the potential contribution of aberrant magnesium transport to cardiovascular disease pathogenesis.
Main Methods:
- Review of existing epidemiological, clinical, and experimental evidence.
- Discussion of cellular mechanisms of magnesium (Mg2+) transport, including influx and efflux pathways.
- Analysis of the role of specific magnesium transporters (e.g., TRPM6/7, SLC41A1) in vascular and renal systems.
Main Results:
- Alterations in magnesium (Mg2+) transport systems, such as altered Na+/Mg2+ exchanger activity or defective TRPM6/7 expression/activity, may lead to hypomagnesemia and intracellular Mg2+ deficiency in hypertension.
- Dysfunctional magnesium transport can impair vascular homeostasis and potentially contribute to the development of hypertension.
- Recent characterization of mammalian cellular Mg2+ transport systems provides new insights into magnesium regulation.
Conclusions:
- Aberrant transcellular magnesium (Mg2+) transport is implicated in the pathogenesis of hypertension and cardiovascular disease.
- Further research is necessary to elucidate the precise mechanisms of Mg2+ regulation in the cardiovascular system.
- Understanding these transport systems is crucial for developing novel therapeutic strategies for cardiovascular conditions.
Related Concept Videos
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...